Int J Stroke:24h动态血压对急性缺血性卒中对短期、中期、长期预后

2015-08-20 phylis 译 MedSci原创

背景:缺血性脑卒中急性期的血压水平与预后之间的关系仍存在争议。目的:这篇综述主要评估脑缺血急性期收缩压和舒张压对卒中预后的预测价值,应用mRS分数评估卒中预后、动态血压监测方法测量血压,并与入院随机测量的血压的预测价值相比。方法:我们搜索卒中24h内入院并且入院24h内进行动态血压监测的患者。我们选取随访结束时,选取血压与良好预后的研究和血压与不良预后的研究。然后对平均血压对预后的影响,进行荟萃分

背景:缺血性脑卒中急性期的血压水平与预后之间的关系仍存在争议。

目的:这篇综述主要评估脑缺血急性期收缩压和舒张压对卒中预后的预测价值,应用mRS分数评估卒中预后、动态血压监测方法测量血压,并与入院随机测量的血压的预测价值相比。

方法:我们搜索卒中24h内入院并且入院24h内进行动态血压监测的患者。我们选取随访结束时,选取血压与良好预后的研究和血压与不良预后的研究。然后对平均血压对预后的影响,进行荟萃分析。

结果:动态监测高收缩压和高舒张压患者与短期,中期,长期不良预后相关;但是在入院随机测量高血压没有得到相同的结果。收缩压增高9.1mmHg (95% CI: 6•6-11•6),舒张压增加2•3 mmHg (95% CI: 0•8-3•7)与不良预后相关。

结论:血压动脉监测测得高收缩压和高收缩压与不良预后相关。入院随机血压测量高血压没有类似结果,可能动态监测血压能够提供更好的预测信息。

原文出处:

Kakaletsis N, Ntaios G, Milionis H,et al; Prognostic value of 24-h ABPM in acute ischemic stroke for short-, medium-, and long-term outcome: a systematic review and meta-analysis.Int J Stroke. 2015 Aug 18. doi: 10.1111/ijs.12609. 


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1892669, encodeId=acb91892669e8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 27 15:37:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806021, encodeId=27f11806021fb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Oct 14 05:37:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645555, encodeId=8f67164555552, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Tue Oct 27 15:37:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508984, encodeId=51551508984b1, content=<a href='/topic/show?id=a7c83311e88' target=_blank style='color:#2F92EE;'>#动态血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33117, encryptionId=a7c83311e88, topicName=动态血压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c1e10025437, createdName=limedical1977, createdTime=Sat Aug 22 03:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1892669, encodeId=acb91892669e8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 27 15:37:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806021, encodeId=27f11806021fb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Oct 14 05:37:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645555, encodeId=8f67164555552, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Tue Oct 27 15:37:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508984, encodeId=51551508984b1, content=<a href='/topic/show?id=a7c83311e88' target=_blank style='color:#2F92EE;'>#动态血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33117, encryptionId=a7c83311e88, topicName=动态血压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c1e10025437, createdName=limedical1977, createdTime=Sat Aug 22 03:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1892669, encodeId=acb91892669e8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 27 15:37:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806021, encodeId=27f11806021fb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Oct 14 05:37:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645555, encodeId=8f67164555552, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Tue Oct 27 15:37:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508984, encodeId=51551508984b1, content=<a href='/topic/show?id=a7c83311e88' target=_blank style='color:#2F92EE;'>#动态血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33117, encryptionId=a7c83311e88, topicName=动态血压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c1e10025437, createdName=limedical1977, createdTime=Sat Aug 22 03:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1892669, encodeId=acb91892669e8, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 27 15:37:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806021, encodeId=27f11806021fb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Oct 14 05:37:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645555, encodeId=8f67164555552, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Tue Oct 27 15:37:00 CST 2015, time=2015-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508984, encodeId=51551508984b1, content=<a href='/topic/show?id=a7c83311e88' target=_blank style='color:#2F92EE;'>#动态血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33117, encryptionId=a7c83311e88, topicName=动态血压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c1e10025437, createdName=limedical1977, createdTime=Sat Aug 22 03:37:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]

相关资讯

Stroke:六分钟核磁共振成像可用于评价急性缺血性卒中

背景及目的:对于急性缺血性卒中患者的评价,核磁共振成像(MRI)与计算机断层扫描相比,仍需要进一步提高采集速度。方法:此项前瞻、单中心研究的入选标准为急性缺血性卒中发作24h表现出临床症状的患者。美国国立卫生研究院卒中量表≥3,无MRI禁忌症。回波平面成像(EPI)结合平行采集技术用于3T磁共振(MR)扫描以加速收集速度。2位神经系放射专家独立分析图像。结果:62位患者符合入选标准,22位患者接受

中国制定血管内治疗新指南的意义何在?

过去十年间,缺血性卒中的再灌注治疗取得了飞速发展。静脉溶栓治疗是迄今唯一被证明有效的治疗方案,但其受到治疗时间窗较窄(4.5h)、再通率低于50%且大血管闭塞对溶栓药物反应不佳的限制。血管内治疗可使这些问题迎刃而解,故国内外学者一直在探索对大血管闭塞患者进行血管内治疗,但研究过程并非一帆风顺。 早期3项多中心、前瞻性、随机对照试验(IMSⅢ、MR

Stroke:急性缺血性卒中和短暂性脑缺血发作后身体活动的量化评估

这项研究的目的是应用加速度计量化评估以及描述缺血性卒中与短暂性脑缺血发作一周之内的患者肢体运动的量与模式。研究方法:总共有100名患有急性缺血性卒中或短暂性脑缺血发作的患者被选中使用我们的急性卒中单元可穿戴Actical加速度计,固定于手腕、脚踝和臀部不超过7天。试验对象主要为症状出现72小时内的患者。利用加速度计的输出结果来测量患者的运动量(AC)。此外,应用斯堪的那维亚卒中量表对患者日常状况进

卒中降压,一定要了解的2项研究和问题

卒中降压,一定要了解的2项研究和2个问题 提到缺血性卒中,早期血压控制是个仍未解决的临床问题,多数指南不建议早期降低升高的血压。然而,许多学者认为把血压控制在一定水平利于改善预后。2014年该领域发表了一系列研究。 需要了解的2项研究 1、ENOS研究 大型国际多中心的ENOS研究,纳入23个国家的4011例急性卒中患者,其中81%为急性缺血性卒中(AIS),16%为

ISC 2015:专家解读剖析急性缺血性卒中血管内治疗四大研究

本文作者:北京天坛医院 缪中荣 北京大学第三医院 李小刚 复旦大学附属华山医院 程忻 董强 发自美国纳什维尔 2015年国际卒中大会(ISC2015)于2月11-13日在美国纳什维尔举行。2月的纳什维尔,天气有些寒冷,但是从全世界赶来的卒中领域专家学者们丝毫没有受到天气的影响。老友相见,互致问候,但更关心的是即将公布的几项有关急性缺血性卒中的临床研究结果。虽然之前对结果已经有所了解,

病例与启示:急性缺血性卒中最合逻辑的治疗

某75岁女性患者,因急性冠脉综合征(ACS)在我院心内科行急诊经皮冠状动脉介入(PCI)手术。 术后予以氯吡格雷和阿司匹林双抗及低分子量肝素抗凝。 术后第7天早8时发现其昏睡、左侧肢体全瘫、偏身痛刺激反应差。据同病房患者提供信息,患者在凌晨3~4点曾用洗手间。 美国国立卫生研究院卒中量表(NIHSS)评分19分,予以计算机体层摄影(CT)急查未见出血,考虑急性缺血性卒中(AIS)、完全前